Clinical Trial

Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A Randomized, Double-Blinded, Placebo-Controlled, Prospective, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Immunotherapy in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma Sensitized to cupressaceae and grasses.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-05-21; most recent amendment 2025-05-07.
Status change: Not Yet Recruiting → Recruiting 2021-07-01
Trial Details
NCT Number NCT04898283
Lead Sponsor Inmunotek S.L.
Conditions Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic
Enrollment 180 participants
Start Date 2021-05-31
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-05-13